Advertisement

Endocrine

, Volume 53, Issue 3, pp 831–838 | Cite as

Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes

  • Nicola CarettaEmail author
  • Saula Vigili de Kreutzenberg
  • Umberto Valente
  • Gabriella Guarneri
  • Alberto Ferlin
  • Angelo Avogaro
  • Carlo Foresta
Original Article

Abstract

Diabetes is an established risk factor for erectile dysfunction (ED). The pathophysiology of ED in diabetic men is multifactorial, but it mainly involves a vascular disorder related to a reduction of endothelial function. Recently, several studies have correlated ED risk factors with vitamin D deficiency. In this study, we evaluate the relationship between 25-hydroxyvitamin D [25(OH)D] levels, erectile dysfunction, and vascular disease, in type 2 diabetes mellitus men (T2DM). In this observational study, 92 T2DM males (58.83 ± 9.73 years) underwent medical history collection, International Index of Erectile Function (IIEF-5) questionnaire, that allows the identification and grading of DE, physical examination, biochemical/hormonal blood tests, and penile echo-color Doppler ultrasonography. T2DM patients with lower 25(OH)D levels (<25 nmol/l) showed higher penile IMT (p < 0.05), waist circonference (p < 0.05), glucose concentrations (p < 0.05), and lower IIEF-5 score (p < 0.005), testosterone concentrations (p < 0.05), and cavernous peak systolic velocity (PSV) (p < 0.05), compared to patients with 25(OH)D >50 nmol/l. 25(OH)D levels were directly correlated with IIEF-5 (R = 0.39; p = 0.0001), testosterone (R = 0.24; p = 0.02), and PSV (R = 0.24; p = 0.04) and inversely with waist (R = −0.33; p = 0.002), HbA1c (R = −0.22; p = 0.03), triglyceride (R = −0.21; p = 0.06), and penile IMT (R = −0.30; p = 0.009). At multivariate analysis, 25(OH)D deficiency remained an independent predictor of DE. We demonstrate a significant association between 25(OH)D deficiency and erectile dysfunction in T2DM men. This association may be due to the influence of 25(OH)D deficiency on cardiovascular risk factor (glycaemia, HDL cholesterol, and triglycerides), testosterone plasma levels and endothelial dysfunction.

Keywords

Vitamin D Diabetes Erectile dysfunction Endothelial function Testosterone 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    E. Selvi, A.L. Burnett, E.A. Platz, Prevalence and risk factors fer erectile dysfunction in the US. Am. J. Med. 120, 151–157 (2007)CrossRefGoogle Scholar
  2. 2.
    L.S. Malavige, J.C. Levy, Erectile dysfunction in diabetes mellitus. J Sex Med 6, 1232–1247 (2009)CrossRefPubMedGoogle Scholar
  3. 3.
    H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay, Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994)PubMedGoogle Scholar
  4. 4.
    C. Gazzaruso, A. Coppola, T. Montalcini et al., Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273–279 (2011)CrossRefPubMedGoogle Scholar
  5. 5.
    M.E. Sullivan, C.S. Thompson, M.R. Dashwood et al., Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. 43, 658–665 (1999)CrossRefPubMedGoogle Scholar
  6. 6.
    K.L. Billups, A.J. Bank, H. Padma-Nathan, S.D. Katz, R.A. Williams, Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int. J. Impot. Res. 20, 236–242 (2008)CrossRefPubMedGoogle Scholar
  7. 7.
    H. Solomon, J.W. Man, G. Jackson, Erectile dysfunction and the cardiovascular patient: endothelial dysfuntion is the common denominator. Heart 89, 251–253 (2003)CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    I.M. Bird, Endothelial nitric oxide synthase activation and nitric oxide funtion: new light throught old windows. J. Endocrinol. 210, 239–241 (2011)CrossRefPubMedGoogle Scholar
  9. 9.
    L. Ghiadoni, S. Taddei, A. Virdis, Hypertension and endothelial dysfunction: therapeutic approach. Curr. Vasc. Pharmacol. 10, 42–60 (2012)CrossRefPubMedGoogle Scholar
  10. 10.
    C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Stefanadis, Inflammation, metabolic syndrom, erectile dysfunction, and coronary artery disease: common links. Eur. Urol. 52(6), 1590–1600 (2007)CrossRefPubMedGoogle Scholar
  11. 11.
    C. Foresta, P.F. Palego, M. Schipilliti et al., Asymmetric development of pheriferal atherosclerosis in patients with erectile dysfunction: an ultrasonographic study. Atherosclerosis 197, 889–895 (2008)CrossRefPubMedGoogle Scholar
  12. 12.
    J.P. Reis, D. von Muhlen, E.D. Michos et al., Serum vitamin D, parathyroid hormone levels and carotid atherosclerosis. Atherosclerosis 207, 585–590 (2009)CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    A.C. Borges, T. Feres, L.M. Vianna, T.B. Paiva, Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34, 897–901 (1999)CrossRefPubMedGoogle Scholar
  14. 14.
    S. Vigili de Kreutzenberg, A. Coracina, A. Volpi et al., Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. NMCD 21, 286–293 (2011)PubMedGoogle Scholar
  15. 15.
    L. Polidoro, G. Properzi, F. Marampon et al., Vitamin D protects human endothelial cells from H(2)O(2) oxidant injury through the Mek/Erk-Sirt1 axis activation. J. Cardiovasc. Transl. Res. 6, 221–231 (2013)CrossRefPubMedGoogle Scholar
  16. 16.
    A. Barassi, R. Pezzilli, G.M. Colpi, M.M. Corsi Romanelli, G.V. Melzi d’Eril, Vitamin D and erectile dysfunction. J. Sex Med. 11, 2792–2800 (2014)CrossRefPubMedGoogle Scholar
  17. 17.
    W.B. Grant, M. Sorenson, B.J. Boucher, Vitamin D deficiency may contribute to the explanation of the link between chronic periodontitis and edectile dysfunction. J. Sex Med. 10, 2353–2354 (2013)CrossRefPubMedGoogle Scholar
  18. 18.
    M. Sorenson, W.B. Grant, Does vitamin D deficiency contribute to erectile dysfunction? Dermatoendocrinology 4, 128–136 (2012)CrossRefGoogle Scholar
  19. 19.
    Y. Song, L. Wang, A.G. Pittas et al., Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5), 1422–1428 (2013)CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    D.J. Al-Tamini, A.F. Ali, Serum 25(OH) D in diabetes mellitus type 2: relation to glycaemic control. J. Clin. Diagn. Res. 7, 2686–2688 (2013)Google Scholar
  21. 21.
    B.J. Boucher, W.G. John, K. Noonan, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 80, 1666–1667 (2004)PubMedGoogle Scholar
  22. 22.
    V. Hirani, Relationship between vitamin D and hyperglycemia in older people from a nationally representative population survey. J. Am. Geriatr. Soc. 59, 1786–1792 (2011)CrossRefPubMedGoogle Scholar
  23. 23.
    R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care 27, 2813–2818 (2004)CrossRefPubMedGoogle Scholar
  24. 24.
    C. Foresta, N. Caretta, G. Corona et al., Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart. Int. J. Androl. 32, 198–211 (2009)CrossRefPubMedGoogle Scholar
  25. 25.
    N. Caretta, P. Palego, Schipilliti et al., Cavernous artery intima media thickness: a new parameter in the diagnosis of vascular erectile dysfunction. J. Sex Med. 6, 1117–1126 (2009)CrossRefPubMedGoogle Scholar
  26. 26.
    F.A. Giuliano, A. Leriche, E.O. Jaudinot, A.S. de Gendre, Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 64, 1196–1201 (2004)CrossRefPubMedGoogle Scholar
  27. 27.
    D. Liu, B.O. Fernandez, A. Hamilton et al., UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J. Invest. Dermatol. 134, 1839–1846 (2014)CrossRefPubMedGoogle Scholar
  28. 28.
    C. Oplander, C.M. Volkmar, A. Paune-Gorgulu et al., Whole body UVA irradiation lowers systemic blood pressure by releae of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ. Res. 105, 1031–1040 (2009)CrossRefPubMedGoogle Scholar
  29. 29.
    G. Corona, G. Rastrelli, S. Filippi et al., Erectile dysfunction and central obesity: an Italian perspective. Asian J. Androl. 16, 581–591 (2014)CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    A.T. Drincic, L.A. Armas, E.E. Van Diest, R.P. Heaney, Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20(7), 1444–1448 (2012)CrossRefPubMedGoogle Scholar
  31. 31.
    E. Wehr, S. Pilz, B.O. Boehm, W. Marz, B. Obermayer-Pietsch, Association of vitamin D status with serum androgen levels in men. Clin. Endocrinol. 73, 243–248 (2010)CrossRefGoogle Scholar
  32. 32.
    S. Pilz, S. Frisch, H. Koertke et al., Effect of vitamin D supplementation on testosterone levels in men. Horm. Metab. Res. 43(3), 223–225 (2011)CrossRefPubMedGoogle Scholar
  33. 33.
    J.M. Blomberg, J.E. Nielsen, A. Jorgensen et al., Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum. Reprod. 25, 1303–1311 (2010)CrossRefGoogle Scholar
  34. 34.
    D.W. Eyles, S. Smith, R. Kinobe, M. Hewison, J.J. McGrath, Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29, 21–30 (2005)CrossRefPubMedGoogle Scholar
  35. 35.
    R. Perez-Fernandez, M. Alonso, C. Segura et al., Vitamin D receptor gene expression in human pituitary gland. Life Sci. 60, 35–42 (1997)CrossRefPubMedGoogle Scholar
  36. 36.
    L.S.F. Carvalho, A.C. Sposito, Vitamin D for the prevention of cardiovascular disease: are we ready for that? Atherosclerosis 241, 729–740 (2015)CrossRefPubMedGoogle Scholar
  37. 37.
    M.I. Ullah, G.I. Uwaifo, W.C. Nicholas, C.A. Koch, Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int. J. Endocrinol. 2010, 579–640 (2010)CrossRefGoogle Scholar
  38. 38.
    O. Andrukhova, S. Slavic, U. Zeitz et al., Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol. Endocrinol. 28, 53–64 (2014)CrossRefPubMedGoogle Scholar
  39. 39.
    M.S. Wong, R. Delansorne, R.Y. Man, P. Svenningsen, P.M. Vanhoutte, Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 299, 1226–1234 (2010)CrossRefGoogle Scholar
  40. 40.
    M. Hirata, K. Serizawa, K. Aizawa et al., 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy. Nephrol. Dial. Transpl. 28, 1166–1174 (2013)CrossRefGoogle Scholar
  41. 41.
    J.J. Cannell, W.B. Grant, M.F. Holick, Vitamin D and inflammation. Dermatoendocrinology 6(1), e983401 (2015)CrossRefGoogle Scholar
  42. 42.
    Y. Talmor, J. Bernheim, O. Klein, J. Green, G. Rashid, Calcitriol blunts proatherosclerotic parameters through NFkappaB and p38 in vitro. Eur. J. Clin. Invest. 38, 548–554 (2008)CrossRefPubMedGoogle Scholar
  43. 43.
    K. Kudo, S. Hasegawa, Y. Suzuki et al., 1alpha,25-dihydroxyvitamin D(3) inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J. Steroid Biochem. Mol. Biol. 132, 290–294 (2012)CrossRefPubMedGoogle Scholar
  44. 44.
    M.P. Ponda, X. Huang, M.A. Odeh, J.L. Breslow, H.W. Kaufman, Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 126, 270–277 (2012)CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Nicola Caretta
    • 1
    Email author
  • Saula Vigili de Kreutzenberg
    • 2
  • Umberto Valente
    • 1
  • Gabriella Guarneri
    • 2
  • Alberto Ferlin
    • 1
  • Angelo Avogaro
    • 2
  • Carlo Foresta
    • 1
  1. 1.Department of Medicine, Section of Endocrinology and Centre for Human Reproduction PathologyUniversity of PadovaPaduaItaly
  2. 2.Section of Diabetes and Metabolic Diseases, Department of MedicineUniversity of PadovaPaduaItaly

Personalised recommendations